Mineralys Therapeutics, Inc.
MLYS
43 insider filings · Latest: Sep 30, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | Feb 14 12:25 AM | David Malcom RodmanChief Medical Officer | Sale | 6,349 | $28.99 | $184.1K | 50,437(D) | View → |
| Feb 13, 2026 | Feb 13 9:07 PM | Rodman David Malcom | Proposed Sale | 14,055 | $27.44 | $385.7K | — | View → |
| Feb 12, 2026 | Feb 12 9:34 PM | Rodman David Malcom | Proposed Sale | 6,349 | $28.99 | $184.1K | — | View → |
| Feb 9, 2026 | Feb 11 11:58 PM | David Malcom RodmanChief Medical Officer | Sale | 2,171 | $30.21 | $65.6K | 50,437(D) | View → |
| Feb 9, 2026 | Feb 9 9:20 PM | Rodman David Malcom | Proposed Sale | 2,171 | $30.21 | $65.6K | — | View → |
| Jan 20, 2026 | Jan 21 1:33 AM | David Malcom RodmanChief Medical Officer | Sale | 416 | $32.10 | $13.4K | 50,437(D) | View → |
| Jan 20, 2026 | Jan 20 9:26 PM | Rodman David Malcom | Proposed Sale | 416 | $32.10 | $13.4K | — | View → |
| Jan 14, 2026 | Jan 14 9:00 PM | Rodman David Malcom | Proposed Sale | 11,367 | $32.61 | $370.6K | — | View → |
| Jan 13, 2026 | Jan 13 9:10 PM | Rodman David Malcom | Proposed Sale | 7,709 | $32.75 | $252.5K | — | View → |
| Jan 12, 2026 | Jan 12 9:24 PM | Rodman David Malcom | Proposed Sale | 6,348 | $32.32 | $205.1K | — | View → |
| Jan 12, 2026 | Jan 12 9:23 PM | Levy Adam Scott | Proposed Sale | 10,758 | $32.14 | $345.7K | — | View → |
| Jan 12, 2026 | Jan 12 9:23 PM | Congleton Jon | Proposed Sale | 16,236 | $32.62 | $529.6K | — | View → |
| Jan 9, 2026 | Jan 9 9:23 PM | Rodman David Malcom | Proposed Sale | 2,170 | $33.27 | $72.2K | — | View → |
| Jan 2, 2026 | Jan 2 10:18 PM | Rodman David Malcom | Proposed Sale | 262,752 | $35.71 | $9.4M | — | View → |
| Nov 20, 2025 | Nov 20 10:19 PM | Catalys Pacific Fund, LP | Proposed Sale | 1,000,000 | $42.12 | $42.1M | — | View → |
| Nov 13, 2025 | Nov 13 9:04 PM | Karydas Daphne | Proposed Sale | 15,000 | $45.99 | $689.8K | — | View → |
| Nov 12, 2025 | Nov 13 9:03 PM | Gold Alexander M | Proposed Sale | 34,675 | $45.45 | $1.6M | — | View → |
| Nov 11, 2025 | Nov 12 9:32 PM | Levy Adam Scott | Proposed Sale | 119,524 | $44.88 | $5.4M | — | View → |
| Nov 11, 2025 | Nov 12 9:28 PM | Congleton Jon | Proposed Sale | 200,000 | $45.44 | $9.1M | — | View → |
| Oct 15, 2025 | Oct 15 8:09 PM | Rodman David Malcom | Proposed Sale | 10,369 | $43.01 | $446.0K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | Apr 16 1:45 AM | David Malcom RodmanChief Medical Officer | Option Exercise | 14,058 | $14.25 | 91,667(D) | View → |
| Apr 9, 2026 | Apr 14 1:13 AM | David Malcom RodmanChief Medical Officer | Option Exercise | 2,170 | $16.00 | 21,706(D) | View → |
| Mar 31, 2026 | Apr 2 10:53 PM | Daphne KarydasDirector | Option Exercise | 3,000 | $12.02 | 41,000(D) | View → |
| Mar 17, 2026 | Mar 17 8:51 PM | David Malcom RodmanChief Medical Officer | Option Exercise | 417 | $15.44 | 5,000(D) | View → |
| Mar 13, 2026 | Mar 16 9:20 PM | David Malcom RodmanChief Medical Officer | Option Exercise | 7,709 | $14.25 | 95,834(D) | View → |
| Mar 12, 2026 | Mar 16 9:20 PM | David Malcom RodmanChief Medical Officer | Option Exercise | 6,348 | $1.08 | 25,395(D) | View → |
| Mar 9, 2026 | Mar 10 9:48 PM | David Malcom RodmanChief Medical Officer | Option Exercise | 2,171 | $16.00 | 23,876(D) | View → |
| Feb 19, 2026 | Feb 21 12:49 AM | RA CAPITAL MANAGEMENT, L.P.Director | Grant/Award | 8,300 | $28.06 | 8,300(I) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Jon CongletonDirector, Chief Executive Officer | Grant/Award | 187,900 | $28.06 | 187,900(D) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Glenn SblendorioDirector | Grant/Award | 8,300 | $28.06 | 8,300(D) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Alexander M GoldDirector | Grant/Award | 8,300 | $28.06 | 8,300(D) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Daphne KarydasDirector | Grant/Award | 8,300 | $28.06 | 8,300(D) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Brian Taylor SlingsbyDirector, 10% Owner | Other (J) | 8,300 | $28.06 | 0(D) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Brian Taylor SlingsbyDirector, 10% Owner | Grant/Award | 8,300 | $28.06 | 8,300(D) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Brian Taylor SlingsbyDirector, 10% Owner | Other (J) | 8,300 | $28.06 | 8,300(I) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Srinivas AkkarajuDirector, 10% Owner | Grant/Award | 8,300 | $28.06 | 8,300(D) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Derek DiroccoDirector | Grant/Award | 8,300 | $28.06 | 8,300(D) | View → |
| Feb 19, 2026 | Feb 21 12:46 AM | David Malcom RodmanChief Medical Officer | Grant/Award | 51,300 | $28.06 | 51,300(D) | View → |
| Feb 19, 2026 | Feb 21 12:46 AM | Adam Scott LevyCFO and Secretary | Grant/Award | 53,300 | $28.06 | 53,300(D) | View → |
| Feb 17, 2026 | Feb 17 11:56 PM | David Malcom RodmanChief Medical Officer | Option Exercise | 417 | $15.44 | 5,417(D) | View → |